The speaker Dr. Markus Tröltzsch (Göttingen) provides a presentation about the use of medication associated with orofacial indications. First, he points out that the majority of infections in the orofacial region is due to odontogenic infections, which are usually caused by multiple bacteria. He notes that the effective concentration of all medicines taken orally is greatly reduced due to first pass metabolism.
For an extended list of odontogenic diseases and other indications associated with the orofacial or craniomandibular system, Dr. Tröltzsch discusses the recommended medicine and its dose (here the dose refers to a patient with a weight of 75kg and needs to be adjusted accordingly). The indications include toothache, apical infections, periodontitis, alveolitis sicca, submucous/subperiosteal abscess, sialadenitis, antibiotic prophylaxis, analgesic therapy after surgery, bone infections, sinusitis, craniomandibular disorders and infections of the mucosa. To relieve or prevent pain, usually, for odontogenic treatments the non-opioid analgesics Ibuprofen and Metamizole are administered.
In order to compensate for the adverse effects of nonsteroidal anti-inflammatory drugs (NSAIDs) on the gastric mucosa, these analgesics are given in combination with the drug Omeprazole/Pantoprazole. Omeprazole/Pantoprazole is a proton-pump inhibitor, which reduces gastric acid and protects the gastric mucosa. If stronger pain relief is needed, opioid pain killers may be used.
For the treatment of certain bacterial infections, the administration of antibiotics is required. In addition to the intake of medicine, in several cases like an abscess or sialadenitis, the expert emphasizes the need of cooling. Medication for pregnant patients is mentioned separately. During pregnancy, the number of medicines that can be applied is limited.